Table 1. Relationship of high MAGE-A9 expression with clinicopathological characteristics in HCC.

		MAGE-A9
Groups	No.	+	%	χ2	p value
Total	100	55	55.0
Gender
Male	83	44	53.0	0.78	0.377
Female	17	11	64.7
Age (years)
<60	76	41	53.9	0.14	0.707
≥60	24	14	58.3
Tumor size (cm)
>5	58	34	58.6	0.73	0.392
≤5	42	21	50.0
α-fetoprotein (AFP) status
High	56	28	50.0	1.29	0.257
Low	44	27	61.4
Hepatitis B virus infection
Positive	66	35	53.0	0.30	0.581
Negative	34	20	58.8
Liver cirrhosis
Positive	42	21	50.0	0.73	0.392
Negative	58	34	58.6
Pathological grade
Grade 1	11	1	9.1	11.74	0.003*
Grade 2	71	41	57.7
Grade 3	18	13	72.2
Portal vein invasion
Positive	38	29	76.3	11.25	0.001*
Negative	62	26	41.9
Lymph node metastasis
Positive	26	18	69.2	2.87	0.090
Negative	74	37	50.0
Distant metastasis
Positive	6	6	100.0	5.22	0.022*
Negative	94	49	52.1
TNM stage
Stage I	13	4	30.8	13.05	0.005*
Stage II	36	15	41.7
Stage III	45	30	66.7
Stage IV	6	6	100.0

*p < 0.05.